Urine tissue inhibitor of metalloproteinases 2 (TIMP-2) combined with insulin-like growth factor binding protein 7 (IGFBP7) sufficiently predict the risk of AKI in patients undergoing major abdominal surgery with an AUC of 0.85 (33). This evidence concerns the gene IGFBP7 and acute kidney injury.